Clinical Trials

Showing trials with last updates posted in 2025.

NCT06813677 | RECRUITING | NA
1000 participants

Innsbruck Health Promotion Program

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2025-05-01
Completion:
2027-01-31
Conditions
  • Assessment of Vascular Health Risk Factors
Interventions
  • OTHER
No Results Yet
NCT06790849 | COMPLETED | NA
45 participants

ETASCAI Pilot Project

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2025-02-24
Completion:
2025-10-22
Conditions
  • Cognition
  • Affect (Mental Function)
  • Inflammation
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT06784648 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
35 participants

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2024-12-11
Completion:
2025-12-30
Conditions
  • Melanoma Metastatic
  • Melanoma of Skin
  • Melanoma BRAF V600E/K Mutated
  • Melanoma Recurrent
  • Melanoma Stage III or IV
  • Melanoma
  • Melanoma Negative for bRAF
  • Melanoma Negative for nRAS
  • Melanomas
  • Uveal Melanoma, Metastatic
Interventions
  • BIOLOGICAL
No Results Yet
NCT06747923 | RECRUITING | PHASE2
30 participants

SB17170 Phase 2 Trial in IPF Patients

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-19
Start Date:
2025-01-27
Completion:
2026-05-30
Conditions
  • IPF
  • Idiopathic Pulmonary Fibrosis
  • Idiopathic Pulmonary Fibrosis (IPF)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page